Nuclear matrix protein, tumor necrosis factor-α, and nitrite/nitrate levels in patients with multiple organ dysfunction syndrome

Research Communications in Molecular Pathology and Pharmacology

Volumn 100, Issue 1, 1998, Pages 92-104

  Yamada, Yasuhiko ^a   Endo, Shigeatsu ^a   Kasai, Takeshi ^a   Koike, Soichi ^a   Takakuwa, Tetsuya ^a   Inoue, Yoshihiro ^a   Niimi, Mitsuhiro ^b   Endo, Yukio ^c   Wakabayashi, Go ^d   Inada, Katsuya ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; NITRITE; NUCLEAR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; STATISTICAL ANALYSIS; SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; APOPTOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NITRATES; NITRITES; NUCLEAR PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17544401121     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ACCP/SCMCC Consensus Conference Committee. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655./Crit Care Med 20: 864-874.
2. ACCP/SCMCC Consensus Conference Committee. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655./Crit Care Med 20: 864-874.
3. Beutler B., Milsark I.W., Cerami A. (1985). Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 35: 3972-3977.
4. Calanda T., Baumgartner J-D., Grau G.E., Wu M-M., Lambert P-H., Schellekins J., Verhoef J., Glauser M.P., the Swiss-Dutch J5 Immunoglobulin Study Group. (1990). Prognostic values of tumor necrosis factor/cachectin, interleukin-1, and interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 16: 982-987.
5. Cho H.J., Xie Q., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., Nathon C. (1992). Calmodulin is a subunit of nitric oxide synthesis from macrophages. J Exp Med 176: 599-604.
6. Endo S., Inada K., Inoue Y., Kuwata Y., Suzuki M., Yamashita H., Hoshi S., Yoshida M. (1992). Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ shock 38: 264-274.
7. Endo S., Inada K., Ceska M., Takakuwa T., Yamada Y., Nakae H., Kasai T., Yamashita H., Taki K., Yoshida M. (1995a). Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflamm 45: 136-142.
8. Endo S., Inada K., Nakae H., Takakuwa T., Kasai T., Yamada Y., Suzuki T., Taniguchi S., Yoshida M. (1995b). Blood levels of endothelin-1 and thrombo-modulin in patients with disseminated intravascular coagulation and sepsis. Res Commun Molecul Pathol Pharmacol 90: 277-288.
9. Endo S., Inada K., Nakae H., Arakawa N., Takakuwa T., Yamada Y., Shimamura T., Suzuki T., Taniguchi S., Yoshida M. (1996a). Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock. Res Commun Molecul Pathol Pharmacol 94: 347-356.
10. Endo S., INada K., Kasai T., Takakuwa T., Yamada Y., Koike S., Wakabayashi G., Niimi M., Taniguchi S., Yoshida M.(1996b). Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm 46:212-219.
11. Endo S., Inada K., Takakuwa T., Kasai T., Yamada Y., Wakabayashi G., Niimi M., Suzuki T., Taniguchi S. (1996c). Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure. Res Commun Molecul Pathol Pharmacol 92: 253-256.
12. Goris R.J.A., te Boekhorst T.P.A., Nuytinck K.S., Gimbrere J.S.F. (1985). Multiple-organ failure: Generalized autodestructive inflammation ? Arch Surg 120: 1109-1115.
13. Gorrlieb R.A., Burleson K.O., Kloner R.A., Baabior B.M., Engler R.L. (1994). Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628.
14. 15N] nitrate in biological fluids. Anal Biol 126:131-138.
15. Kanno K., Hirata Y., Imai T., Marumo F. (1993). Induction of nitric oxide synthesis gene by interleukin in vascular smooth muscle cells. Hypertension 22:34-39.
16. Inada K., Endo S., Takahashi K., Suzuki M., Narita T., Yoshida T., Suda H., Komuro T., Yoshida M. (1990). Establishment of a new perchloroc acid treatment method to allow determination of the total endotoxin content in human plasma by the limulus test and clinical application. Microbiol Immunol 35: 303-314.
17. Kilbourn R., Jubran A., Gross S.S., Griffin O.W., Levi R., Adams J., Lodato R. (1990). Reversa of endotoxin-mediated shock by N-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132-1138.
18. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. (1985). APACHE II: A severity of disease classification system. Crit Care Med 13: 818-829.
19. Kolb H. and Kolb-Bachofen V. (1992). A pathogenic factor in autoimmunity. Immunol Today 13: 157-160.
20. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., Glembotski C.C., Quintana P.J.E., Sabbadini R.A. (1996). Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854-2865.
21. Lee A., Whyte M.K.B., Haslett C. (1993). Inhibition of apoptosis and prolongation: Programmed cell death in the neutrophil; functional longevity by inflammatory mediators. J Leukocyte Biol 54: 283-288.
22. Lei S.Z., Pan Z., Aggarwal S.K., Chen H-S., Hartman J., Sucher N.J., Lipton S.A. (1992). Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex.Neuron 8: 1087-1099.
23. Luscher T.F. and Vanhooutte P.M. (1990). The endothelium: Modulator of cardiovascular function. CRC Press, pp. 1-228.
24. Marshall J.C., Cook D.J., Christou N.V.. (1995). Multiple organ dysfunction score: A reliable descriptor of a comples clinical outcome. Crit Care Med 23: 1638-1652.
25. Miller T.E., Beausang L.A., Winchell L.F., Lidgard G.P. (1992).Detection of nuclear matrix proteins in serum from cancer patients. Cancer 52: 422-427.
26. Miller T.E., Beausang L.A., Meneghini M., Lidgard G. (1993). Death-induced changes to the nuclear matrix protein: the use of anti-nuclear matrix antibodies to study agents of apoptosis. Bio Techniques 15: 1042-1047.
27. Moncada S., Palmer R.M.J., Higgs E.A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
28. Nakae H., Endo S., Inada K., Takakuwa T., Kasai T. (1996a). Changes in adhesion molecules levels in sepsis. Res Commun Molecul Pathol pharmacol 91: 329-338.
29. Nakae H., Endo S., Inada K., Yamada Y., Takakuwa T., Yoshida M. (1996b). Plasma endothelin-1 and thrombomodulin in burn patients. Burns 22: 594-597.
30. Nakamura Y., Komatsu N., Nakauchi H. (1992). A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257: 1138-1141.
31. Nitatori T., Sato N., Waguri S., Karasawa Y., Arai H., Shibanai K., Kominami E., Uchiyama Y. (1995). Delayed neuronal death in the CAI pyramidal cell layer of the hippocampus following transient ischemia is apoptosis. J Neurosci 15: 1001-1011.
32. Obayashi T., Tamura H., Tanaka S., Ohki M., Takahashi S., Aral M., Matsuda M., Kawai T. (1985). New chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 149:55-65.
33. Ochoa J., Curti B., Peitzman A.B, Simmons, R.L., Billar, T.R., Hoffman, R., Rault R., Longo, D.L., Urba, W.J., Ochola, A.C. (1992). Increased circulating oxides after human tumor immunotherapy with toxic hemodynamic changes. J Natl Cancer Inst 84: 964-967.
34. Okusawa S., Gelfand J.A., Ikejima T., Conoolly R.J., Dinarello C.A. (1988). Interleukin 1 induces shock-like state in rabbits: Synergism with tumor necrosis factors and effects of cyclooxygenase inhibition. J Clin Invest 81: 1162-1172.
35. Parchment R. (1991). Programmed cell death (apoptosis) in murine blastocytes: Extracellular free-radicals, polyamines, and other cytotoxic agents. In vitro 5: 493-500.
36. Sarih M., Souvannavong V., Adam A. (1993). Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 191: 503-508.
37. Schumer M., Colombet M.C., Sawczuk I.S., gobe G., Connor J., O'Toole K.M., Olsson C.A., Wise G.J., Buttyant R. (1992). Biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-835.
38. Takakuwa T., Endo S., Nakae H., Kikuchi M., Suzuki T., Inada K., Yoshida M. (1994). Plasma levels of TNF-α, endothelin-1 and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol 84: 261-269.
39. Tanaka M., Suda T., Takahashi T., Nagata S. (1995). Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14: 1129-1135.
40. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsarl I.W., Hariri R.J., Fahey T.J.III, Zentella A., Albert J.D., Shires G.T., Cerami C.A. (1985). Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474.
41. Yamashita K., Niwa M., Kataoka Y., Shigematsu K., Nimeno A., Tsutsumi K., Nakano-Nakashima, Sakurai-Yamashita Y., Shibata S., Tanigawa K. (1994). Microglia with an endothelin ETB receptor aggregate in rat hyppocampus CAI subfields following transient forebrain ischemia. J Neurochem 63: 1042-1051.
42. Yonehara S., Ishii A., Yonehara M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756.